Infusion System Market Research Report- Forecast To 2030

Infusion System Market Share, Growth And Trends Analysis By Product Type (Iv Disposable, Infusion Pump, Others); By Application (Chemotherapy, Diabetes, Gastrointestinal Diseases, Pediatrics, And Others); By End User (Hospitals, Specialty Oncology Wards, Homecare) - Forecast To 2030

ID: MRFR/MED/0703-CR | May 2017 | Region: Global | 168 Pages         

Infusion Systems Market Speak to Analyst Request a Free Sample

Infusion System Market Overview


The infusion system market is projected to reach USD 10,800 Million by 2030 at 8.90% CAGR during the forecast period 2022-2030. An infusion system is basically an infusion pump that is widely used to infuse fluids nutrients or medication into the body of the patient’s circulatory system. It is widely used intravenously and it is occasionally used for epidural and arterial infusions as well. It is generally used to manage or treat neurological disorders or conditions of the nervous system.


There are several factors that are a contribution to the growth of the global infusion system market such as the increased demand for the infusion pumps for infusing drugs or other essential fluids, increasing prevalence of fatal diseases and chronic diseases, the rise in demand for the infusion pumps in the military units o medical, advancement in technology of these surgical drug infusion system from the key players of the market. However, the concerns about the consequences of the systems and the low-income countries that can’t afford to supply such systems to their medical units are the major causes that are creating hurdles in the growth of the global infusion system global market. 


This report contains all the information on the global infusion system market research and the market strengths. The report also contains the culmination of dynamics, segmentation, key players, regional analysis, and other important factors. And a detailed analysis of the global infusion system market report and forecast to 2025 is also included in the report.


Covid 19 Analysis


The outbreak of the global pandemic has led numerous health workers to resort to place infusion systems outside the patient so that they can manage the medications of the patients from several feet away. The immune system infusion therapy is widely used for the hospitalized covid 19 patients is vital in the global infusion system market. Moreover, the outbreak of the covid 19 has left a positive impact on the global infusion system market and it is expected to add fuel to the growth of the infusion system market.  


Market Dynamic



  • Drivers


The rising incidence of cardiovascular diseases and chronic diseases leading to diabetes are the major factors that are driving the growth of the global infusion system market during the forecast period 2020 to 2025. Moreover, the rising patients of with diabetes and their adaptation to different types of infusion pumps are raising the demands for the infusion system market during the forecast period.



  • Opportunities


The benefit of the intravenous infusion system in administering medication, amino acids, minerals, and several essential micronutrients can create opportunities infusion system market by adding to the infusion for collateral nutrition. Smart infusion systems are technologically advanced with automation, drug libraries, operators, and the safety features for accurate and precise results of patients, it also helps in delivering controlled fluids into the patient systems.

  • Restraints


The improper disposable infusion pumps and the rising concerns about the safety of patients are leading to create several consequences and unmet needs of medical in the low-income countries are likely to hamper the growth of the global infusion system market.

  • Challenges


The stringent regulation of governments for launching new device approval is the major factor that is restraining the infusion systems market during the forecast period 2020 to 2025. Furthermost, the U.S Foods and Drugs Administration has written a letter to the manufacturers of infusion systems where they are describing the problems related to the controlled release infusion system which serves as a major setback for the growth of the global infusion system market.


Cumulative Growth Analysis


North America is predicted to rule the major drug infusion market size due to the rapid rise in the technological advancement of the developed countries. North America is predicted to influence USD 3.49 Billion by the end of the year 2023.


Value Chain Analysis


According to the latest report, the global infusion system market has been segmented on the basis of product type which comprises IV disposable, infusion pump, and others. IV disposable accounts for the maximum market share of the total market revenue in 2016. On the basis of application, the global infusion system market has been segmented into gastrointestinal diseases, chemotherapy, diabetes, pediatrics, and others. The chemotherapy segment accounts for the maximum infusion system share of the total market in the year 2016.


On the basis of end-users, the global infusion system market has been segmented into specialist oncology wards, hospitals, homecare, others. A hospital segment is expected to dominate the global infusion system market with the maximum market share in the year 2016.


Segmentation Overview


The market is segmented on the basis of product type which comprises of IV disposable, infusion pump, and others. The global infusion system market is expected to witness decent growth during the forecast period.


By Application


Based on the application, the market is segmented into oncology, gastrointestinal diseases, cardiology, and musculoskeletal disorders.


By end-users


Based on the propulsion types, the market is segmented into diagnostic centers, and hospitals & clinics.


Regional Analysis


According to the reports, on the basis of region, the global infusion system market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is the largest infusion system market and it is predicted to commands the largest share in the market due to rising advanced technologies in this region. Europe held the second-largest share in the market followed by Asia pacific and this region offers lots of opportunities due to the continuously growing economies of the countries in this region. The developments of health care sectors and improvised economies and increased disposable income per individual are the major factors that are boosting the demand for the infusion systems in this region. The Middle East and Africa are less developed economies and exceptionally low-income accounts for the minimum market share in the year 2016 but it is predicted to grow with better infusion treatment in the countries.


Competitive landscape


The prominent key players of the global infusion system market companies are focused on making strategies through innovation, developments in products, and mergers & acquisitions.


Major Key Players



  • ¬† ¬† ¬† ¬† Becton

  • ¬† ¬† ¬† ¬† Dickinson and Company (US)

  • ¬† ¬† ¬† ¬† B. Braun Melsungen AG (Germany)

  • ¬† ¬† ¬† ¬† Baxter International Inc. (US)

  • ¬† ¬† ¬† ¬† Fresenius Kabi (Germany)

  • ¬† ¬† ¬† ¬† ICU Medical, Inc. (US)

  • ¬† ¬† ¬† ¬† Medtronic plc (Ireland), Moog Inc. (US)

  • ¬† ¬† ¬† ¬† Smiths Medical (US)

  • ¬† ¬† ¬† ¬† Terumo Corporation (Japan)

  • ¬† ¬† ¬† ¬† NIPRO Corporation (Japan)

  • ¬† ¬† ¬† ¬† Avanos Medical, Inc. (US)

  • ¬† ¬† ¬† ¬† Tandem Diabetes Care, Inc. (US)

  • ¬† ¬† ¬† ¬† JMS Co., Ltd. (Japan)

  • ¬† ¬† ¬† ¬† Insulet Corporation (US)

  • ¬† ¬† ¬† ¬† Roche Diagnostics (Switzerland)

  • ¬† ¬† ¬† ¬† Zyno Medical (US)

  • ¬† ¬† ¬† ¬† Teleflex, Inc. (US)

  • ¬† ¬† ¬† ¬† Mindray Medical International Limited (China)

  • ¬† ¬† ¬† ¬† Micrel Medical Devices SA (Greece)

  • ¬† ¬† ¬† ¬† Ypsomed Holding AG (Switzerland).


Report Overview


The following report comprises of ‚Äď



  • ¬† ¬† ¬† ¬† Market overview¬†

  • ¬† ¬† ¬† ¬† Covid 19 Analysis

  • ¬† ¬† ¬† ¬† Market Dynamic

  • ¬† ¬† ¬† ¬† Drivers

  • ¬† ¬† ¬† ¬† Opportunities

  • ¬† ¬† ¬† ¬† Restraints¬†

  • ¬† ¬† ¬† ¬† Challenges

  • ¬† ¬† ¬† ¬† Cumulative Growth Analysis

  • ¬† ¬† ¬† ¬† Value Chain Analysis

  • ¬† ¬† ¬† ¬† Segmentation Overview¬†

  • ¬† ¬† ¬† ¬† By Application¬†

  • ¬† ¬† ¬† ¬† By End-Users

  • ¬† ¬† ¬† ¬† Regional Analysis

  • ¬† ¬† ¬† ¬† Competitive landscape


Recenet Developments



  • In January 2020, Medtronic (Ireland) Launched Efficio, a cloud-based data management software, for use with the SynchroMed II intrathecal drug delivery system. This enables clinicians to efficiently manage their targeted drug delivery pump practices to treat patients with chronic pain, cancer, and severe spasticity.


The research report categorizes the market into the following segments and subsegments:


By Product




  • Accessories & Consumables


    • Dedicated Accessories & Consumables

      • Volumetric Infusion Pumps

      • Insulin Infusion Pumps

      • Enteral Infusion Pumps

      • Syringe Infusion Pumps

      • Ambulatory Infusion Pumps

      • PCA Pumps

      • Implantable Infusion Pumps




    • Non-Dedicated Accessories & Consumables

      • Infusion Catheters

      • IV/Administration Sets

      • Needleless Connectors

      • Cannulas

      • Tubing & Extension Sets

      • Valves

      • Other Non-dedicated Accessories & Consumables






  • Devices


    • By Product

      • Volumetric Infusion Pumps

      • Enteral Infusion Pumps


      • Ambulatory Infusion Pumps

        • Disposable Infusion Pumps

        • Chemotherapy Infusion Pumps



      • Syringe Infusion Pumps

      • Insulin Infusion Pumps

      • PCA Pumps

      • Implantable Infusion Pumps




    • By Type

      • Traditional Infusion Pumps

      • Specialty Infusion Pumps






By Application



  • Chemotherapy/Oncology

  • Diabetes

  • Gastroenterology

  • Analgesia/Pain Management

  • Pediatrics/Neonatology

  • Hematology

  • Other Applications


By End User



  • Hospitals

  • Home Care Settings

  • Ambulatory Care Settings

  • Academic & Research Institutes


By Region




  • North America

    • US

    • Canada




  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Rest of Europe (RoE)




  • Asia Pacific

    • Japan

    • China

    • India

    • Rest of Asia Pacific (RoAPAC)




  • Latin America

    • Brazil

    • Mexico

    • Rest of Latin America (RoLA)



  • Middle East & Africa



Report Scope:

Report Attribute/Metric Details
  Market Size   USD 10,800 Million
  CAGR   8.90%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Application and End User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   3M, B. BRAUN MELSUNGEN AG, Baxter, Becton, Dickinson and Company, Fresenius Kabi AG, ICU Medical, Inc, Smiths Medical, and Terumo Medical Corporation
  Key Market Opportunities   Joint ventures, strategic alliances, mergers and acquisitions, new product developments
  Key Market Drivers

  • Rising prevalence of chronic and fatal diseases
  • high demand of the infusion systems in the military medical units


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The global infusion systems market valuation is expected at USD 10,800 Millionby 2030.

    The global infusion systems market is expected to grow at 8.90% CAGR from 2022-2030.

    Technological breakthroughs from market leaders, demand of infusion units in the military, and prevalence of chronic diseases are major drivers of the global infusion systems market.

    Unmet medical needs in low-income countries and concerns regarding infusion are major challenges of the global infusion systems market.

    North America will dominate the global infusion systems market and will fetch close to USD 15.79 billion by 2025.

    APAC is predicted to generate the fastest revenue for the global infusion systems market at a CAGR of 5.3% from 2020 to 2027.

    Terumo Medical Corporation, Becton, Dickinson and Company, ICU Medical, Inc, Fresenius Kabi AG, Smiths Medical, B. BRAUN MELSUNGEN AG, 3M, and Baxter are major players of the global infusion systems market.